| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
11,270,000 |
| Market
Cap: |
277.13(M) |
| Last
Volume: |
197,427 |
Avg
Vol: |
196,871 |
| 52
Week Range: |
$13.82 - $26.35 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile XOMA is a biotech royalty aggregator. Co. has a portfolio of economic rights to milestone and royalty payments associated with partnered pre-commercial therapeutic candidates. Co.'s portfolio was built through licensing its proprietary products and platforms from its discovery and development business, combined with acquisitions of rights to milestones and royalties.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
14,600 |
117,800 |
| Total Buy Value |
$0 |
$0 |
$268,048 |
$2,088,813 |
| Total People Bought |
0 |
0 |
2 |
3 |
| Total Buy Transactions |
0 |
0 |
13 |
21 |
| Total Shares Sold |
0 |
0 |
0 |
27,000 |
| Total Sell Value |
$0 |
$0 |
$0 |
$809,425 |
| Total People Sold |
0 |
0 |
0 |
2 |
| Total Sell Transactions |
0 |
0 |
0 |
2 |
| End Date |
2024-01-18 |
2023-10-17 |
2023-04-18 |
2022-04-18 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Sitko Bradley |
Chief Investment Officer |
• – – |
2023-10-03 |
4 |
B |
$13.89 |
$3,473 |
D/D |
250 |
5,600 |
0.01 |
51% |
|
| Sitko Bradley |
Chief Investment Officer |
• – – |
2023-10-02 |
4 |
B |
$14.25 |
$21,375 |
D/D |
1,500 |
5,350 |
0.01 |
46% |
|
| Hughes Owen |
Exec Chairman and Interim CEO |
• • – |
2023-10-02 |
4 |
B |
$13.83 |
$13,830 |
D/D |
1,000 |
3,500 |
0.01 |
46% |
|
| Hughes Owen |
Exec Chairman and Interim CEO |
• • – |
2023-09-26 |
4 |
B |
$14.43 |
$36,061 |
D/D |
2,499 |
2,500 |
0.01 |
41% |
|
| Hughes Owen |
Exec Chairman and Interim CEO |
• • – |
2023-09-25 |
4 |
B |
$14.65 |
$15 |
D/D |
1 |
1 |
0.01 |
38% |
|
| Sitko Bradley |
Chief Investment Officer |
• – – |
2023-05-31 |
4 |
B |
$17.00 |
$25,700 |
I/I |
1,500 |
3,500 |
0.01 |
-10% |
|
| Hughes Owen |
Interim CEO |
• • – |
2023-05-24 |
4 |
B |
$23.79 |
$24,551 |
D/D |
1,032 |
2,000 |
0.01 |
-22% |
|
| Hughes Owen |
Interim CEO |
• • – |
2023-05-23 |
4 |
B |
$23.33 |
$22,706 |
D/D |
968 |
968 |
0.01 |
-24% |
|
| Sitko Bradley |
Chief Investment Officer |
• – – |
2023-05-23 |
4 |
B |
$19.00 |
$16,150 |
D/D |
850 |
3,850 |
0.01 |
-24% |
|
| Sitko Bradley |
Chief Investment Officer |
• – – |
2023-05-19 |
4 |
B |
$19.50 |
$19,500 |
D/D |
1,000 |
3,000 |
0.01 |
-27% |
|
| Sitko Bradley |
Chief Investment Officer |
• – – |
2023-05-16 |
4 |
B |
$23.19 |
$11,602 |
I/I |
500 |
2,000 |
0.01 |
-28% |
|
| Sitko Bradley |
Chief Investment Officer |
• – – |
2023-05-15 |
4 |
B |
$23.40 |
$35,100 |
I/I |
1,500 |
1,500 |
0.01 |
-22% |
|
| Sitko Bradley |
Chief Investment Officer |
• – – |
2023-05-12 |
4 |
B |
$18.66 |
$37,985 |
D/D |
2,000 |
2,000 |
0.01 |
-18% |
|
| Lampert Mark N |
Director |
– • • |
2023-01-06 |
4 |
B |
$21.98 |
$71,419 |
D/D |
3,249 |
1,618,637 |
3.92 |
-3% |
|
| Lampert Mark N |
Director |
– • • |
2023-01-05 |
4 |
B |
$18.39 |
$349,319 |
D/D |
19,000 |
1,617,064 |
3.92 |
-6% |
|
| Lampert Mark N |
Director |
– • • |
2022-09-27 |
4 |
B |
$16.89 |
$28,409 |
D/D |
1,682 |
1,601,394 |
3.92 |
20% |
|
| Lampert Mark N |
Director |
– • • |
2022-09-26 |
4 |
B |
$16.83 |
$107,050 |
D/D |
6,360 |
1,600,716 |
3.92 |
22% |
|
| Lampert Mark N |
Director |
– • • |
2022-09-23 |
4 |
B |
$16.50 |
$273,850 |
D/D |
16,600 |
1,597,695 |
3.92 |
20% |
|
| Lampert Mark N |
Director |
– • • |
2022-09-16 |
4 |
B |
$17.89 |
$434,536 |
D/D |
24,293 |
1,773,780 |
3.92 |
18% |
|
| Lampert Mark N |
Director |
– • • |
2022-09-15 |
4 |
B |
$17.96 |
$100,138 |
D/D |
5,575 |
1,576,913 |
3.92 |
14% |
|
| Lampert Mark N |
Director |
– • • |
2022-09-14 |
4 |
B |
$17.25 |
$456,044 |
D/D |
26,441 |
1,571,338 |
3.92 |
18% |
|
| Burns Thomas M. |
SVP, Finance & CFO |
• – – |
2022-07-15 |
4 |
AS |
$31.66 |
$63,321 |
D/D |
(2,000) |
6,555 |
|
-18% |
|
| Burns Thomas M. |
SVP, Finance & CFO |
• – – |
2022-07-15 |
4 |
OE |
$4.03 |
$8,060 |
D/D |
2,000 |
8,555 |
|
- |
|
| Neal James R |
CEO |
• • – |
2022-07-15 |
4 |
AS |
$29.55 |
$746,104 |
D/D |
(25,000) |
11,822 |
|
-18% |
|
| Neal James R |
CEO |
• • – |
2022-07-15 |
4 |
OE |
$4.03 |
$100,750 |
D/D |
25,000 |
36,822 |
|
- |
|
594 Records found
|
|
Page 1 of 24 |
|
|
0.21 (0.86%) 
